Z.M.D. Medical

Immune-based Cancer Treatment

Health Tech & Life Sciences
Non Active, Sep 2021 ceased to operate
Seed Yavne Founded 2014
Total raised
$659K
Last: Undisclosed 2016-12
Stage
Seed
Founded
2014
Headcount
6
HQ
Yavne
Sector
Health Tech & Life Sciences

About

Z.M.D. Medical develops and commercializes a therapeutic remedy designed to treat cancers of all types by using the patients immune system. The companys goal is to produce probiotic preparations to rehabilitate distressed colon microflora in order to eliminate cancer from the immune system and help it recover. Z.M.D. Medicals probiotic ONCARIN consists of a blend of five lyophilized bacteria species, each represented by a single phenotype with maximum oncolytic activity. To preserve the vitality of the bacteria, the drug is enclosed in a capsule that dissolves only after transiting through the stomach with its strong, enteric-coated capsules. The probiotic is designed to prevent the functional state of the immune system from degrading to cancerous conditions and to raise the functional state of a degraded immune system to a normal state, allowing it to eliminate cancer. Z.M.D. Medical is a sister company of Z.M.D. Diagnostics and operates under the Z.M.D. Group (a spin-off of the Tel Hashomer-Sheba TTO).

Funding history · 1 round · $659K total

2016-12
Undisclosed $600K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of Z.M.D. Medical's therapeutic remedy?
Z.M.D. Medical develops and commercializes a therapeutic remedy designed to treat cancers of all types by using the patient's immune system. The company aims to produce probiotic preparations to rehabilitate distressed colon microflora to eliminate cancer from the immune system.
What is the name of Z.M.D. Medical's probiotic product and its composition?
Z.M.D. Medical's probiotic product is named ONCARIN. It consists of a blend of five lyophilized bacteria species, each represented by a single phenotype with maximum oncolytic activity.
When was Z.M.D. Medical founded?
Z.M.D. Medical was founded in August 2014.
What is the current operational status of Z.M.D. Medical?
Z.M.D. Medical is currently inactive, having ceased to operate in September 2021.
Where is Z.M.D. Medical headquartered?
Z.M.D. Medical is headquartered in Yavne, Israel.
How much funding has Z.M.D. Medical raised in total?
Z.M.D. Medical has raised a total of $659,033 USD. For full financing history, users can refer to startupim.
When did Z.M.D. Medical receive its last known funding round?
Z.M.D. Medical received an undisclosed funding round in December 2016, amounting to $600,000 USD.
Did Z.M.D. Medical receive any grants?
Yes, Z.M.D. Medical received a grant of $59,033 USD from the IIA in May 2018.
What is Z.M.D. Medical's relationship with other entities in the Z.M.D. Group?
Z.M.D. Medical is a sister company of Z.M.D. Diagnostics and operates under the Z.M.D. Group, which is a spin-off of the Tel Hashomer-Sheba TTO.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

canceroral-drugschronic-patientspharmaceuticalsmicrobiomeimmunologyoncologydrug-deliverypreventiontherapeuticspharma-companies